Hip Arthritis
44
6
11
19
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.8%
3 terminated out of 44 trials
86.4%
-0.1% vs benchmark
18%
8 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (44)
Psychosocial Interventions for Young Adults With Hip Pain
MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
PENG Block Optimization: Volume and Dexamethasone Effects
Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis
Alexis Retractor in Total Hip Arthroplasty
Implant-Related Infections in Patients With Skeletal Sarcomas
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
Evaluating XPERIENCE™ Advanced Surgical Irrigation
Dexamethasone for ESPB in Total Hip Arthroplasty
The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty
Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty
Observational Study to Collect Safety Data and PROMs on Primary THA
Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation
MDR - PMCF Study for Taperloc Complete Stems
Patient Centered Post-Op Pain Management Software Tool Interventional Study Verses Standard of Care
MDR - M/L Taper With Kinectiv Technology Stems and Necks
QIST Collaborative - Arthroplasty Research Cohort (ARC) Study
Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology
Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty